CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma

Molecular Human Reproduction

Volumn 20, Issue 11, 2014, Pages 1144-1157

  Sales, Kurt J ^a   Adefuye, Anthonio ^a   Nicholson, Lauren ^a   Katz, Arieh A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cervical cancer; Chemokine receptors; Cyclooxygenase; Seminal plasma

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CYCLOOXYGENASE 1; DOXYCYCLINE; ELASTASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOSAMINOGLYCAN; PROSTAGLANDIN E2; CCR5 PROTEIN, HUMAN; MESSENGER RNA; PTGS1 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CANCER CELL; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL PLASMA; SIGNAL TRANSDUCTION; SPERMATOZOON; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; UPREGULATION; UTERINE CERVIX; UTERINE CERVIX CANCER; WESTERN BLOTTING; GENETICS; MALE; METABOLISM; PHYSIOLOGY; SPERM; UTERINE CERVIX TUMOR;

ADULT; ANTIGENS, CD4; CYCLOOXYGENASE 1; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; RECEPTORS, CCR5; RNA, MESSENGER; SEMEN; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84907402678     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gau063     Document Type: Article

References (55)

1. Abera AB, Sales KJ, Catalano RD, Katz AA, Jabbour HN. EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway. Cell Signal 2010;22:71-79.
2. Adefuye A, Sales K. Regulation of inflammatory pathways in cancer and infectious disease of the cervix. Scientifica (Cairo) 2012;2012:548150.
3. Amine A, Rivera S, Opolon P, Dekkal M, Biard DS, Bouamar H, Louache F, McKay MJ, Bourhis J, Deutsch E et al. Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells. PLoS One 2009;4:e5018.
4. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001;285:47-51.
5. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22:2675-2686.
6. Battersby S, Sales KJ, Williams AR, Anderson RA, Gardner S, Jabbour HN. Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum Reprod 2007;22:36-44.
7. Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, Osterhaus AD. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J Virol 2005;79:1686-1700.
8. Castle PE, Giuliano AR. Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr 2003:29-34.
9. Cherukuri DP,Chen XB,GouletAC,YoungRN,HanY,Heimark RL,ReganJW, Meuillet E, Nelson MA. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells. Exp Cell Res 2007;313:2969-2979.
10. Dezzutti CS, Guenthner PC, Cummins JE Jr., Cabrera T, Marshall JH, Dillberger A, Lal RB. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis 2001;183:1204-1213.
11. Doranz BJ, Lu ZH, Rucker J, Zhang TY, Sharron M, Cen YH, Wang ZX, Guo HH, Du JG, Accavitti MA et al. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J Virol 1997;71:6305-6314.
12. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004;2:33-42.
13. Gupta P, Collins KB, Ratner D, Watkins S, Naus GJ, Landers DV, Patterson BK. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol 2002;76:9868-9876.
14. Hirata Y, Uchihashi M, Hazama M, FujitaT. Epidermal growth factor in human seminal plasma. Horm Metab Res 1987;19:35-37.
15. Isaacman-Beck J, Hermann EA, Yi Y, Ratcliffe SJ, Mulenga J, Allen S, Hunter E, Derdeyn CA, Collman RG. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J Virol 2009;83:8208-8220.
16. Jabbour HN, Sales KJ, Catalano RD, Norman JE. Inflammatory pathways in female reproductive health and disease. Reproduction 2009;138:903-919.
17. Joseph T, Zalenskaya IA, Sawyer LC, ChandraN, Doncel GF. Seminal plasma induces prostaglandin-endoperoxide synthase (PTGS) 2 expression in immortalized human vaginal cells: involvement of semen prostaglandin E2 in PTGS2 upregulation. Biol Reprod 2013;88:13.
18. Kelly RW. Immunosuppressive mechanisms in semen: implications for contraception. Hum Reprod 1995;10:1686-1693.
19. Kim KA, Yolamanova M, Zirafi O, Roan NR, Standker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM et al. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 2010;7:55.
20. Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol 2007;18:70-76.
21. Levine AM. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst 1993;85:1382-1397.
22. Maher D,WuX, Schacker T, Horbul J, Southern P. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci USA 2005;102:11504-9.
23. Meng G,WeiX,WuX, SellersMT, Decker JM, Moldoveanu Z, Orenstein JM, Graham MF, Kappes JC, Mestecky J et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med 2002;8:150-156.
24. Mondor I, Ugolini S, Sattentau QJ. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J Virol 1998;72:3623-3634.
25. Muller M, Sales KJ, Katz AA, Jabbour HN. Seminal plasma promotes the expression of tumorigenic and angiogenic genes in cervical adenocarcinoma cells via the E-series prostanoid 4 receptor. Endocrinology 2006;147:3356-3365.
26. Musey L, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath MJ. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med 1997;185:293-303.
27. Ostrowski MA, Justement SJ, CatanzaroA, Hallahan CA, Ehler LA, Mizell SB, Kumar PN, Mican JA, Chun TW, Fauci AS. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998;161:3195-3201.
28. Politch JA, Tucker L, Bowman FP, Anderson DJ. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod 2007;22:2928-2935.
29. Prakash M, Patterson S, Kapembwa MS. Evaluation of the cervical cytobrush sampling technique for the preparation ofCD45+mononuclear cells from the human cervix. J Immunol Methods 2001;258:37-46.
30. Rizzo MT.Cyclooxygenase-2 in oncogenesis. Clin Chim Acta 2011;412:671-687.
31. Robertson SA. Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res 2005;322:43-52.
32. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Analytical and quantitative cytology and histology. Anal Quant Cytol Histol 2001;23:291-299.
33. Ryu HS, Chang KH, Yang HW, Kim MS, Kwon HC, Oh KS. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol 2000;76:320-325.
34. Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 2003;71:97-117.
35. Sales KJ, Katz AA. Inflammatory pathways in cervical cancer-the UCT contribution. S Afr Med J 2012;102:493-496.
36. Sales KJ, Katz AA, Davis M, Hinz S, Soeters RP, Hofmeyr MD, Millar RP, Jabbour HN. Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 2001;86:2243-2249.
37. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/ paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 2002a;62:424-432.
38. Sales KJ, Katz AA, Millar RP, Jabbour HN. Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells. Mol Hum Reprod 2002b;8:1065-1070.
39. Sales KJ, Grant V, Jabbour HN. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol 2008;285:51-61.
40. Sales KJ, Maldonado-Perez D, Grant V, Catalano RD,Wilson MR, Brown P, Williams AR, Anderson RA, Thompson EA, Jabbour HN. Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway. Biochim Biophys Acta 2009;1793:1917-1928.
41. Sales KJ, GrantV,Cook IH, Maldonado-Perez D, Anderson RA,Williams AR, Jabbour HN. Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1. Am J Pathol 2010; 176:435-445.
42. Sales KJ, Grant V, Catalano RD, Jabbour HN. Chorionic gonadotrophin regulates CXCR4 expression in human endometrium via E-series prostanoid receptor 2 signalling to PI3K-ERK1/2: implications for fetal-maternal crosstalk for embryo implantation. Mol Hum Reprod 2011; 17:22-32.
43. Sales KJ, Sutherland JR, Jabbour HN, Katz AA. Seminal plasma induces angiogenic chemokine expression in cervical cancer cells and regulates vascular function. Biochim Biophys Acta 2012;1823:1789-1795.
44. Sharkey DJ, Macpherson AM, Tremellen KP, Mottershead DG, Gilchrist RB, Robertson SA. TGF-beta mediates proinflammatory seminal fluid signaling in human cervical epithelial cells. J Immunol 2012a;189:1024-1035.
45. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson, Robertson SA. Seminal Fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol 2012b;188:2445-2454.
46. Shimizu N, Tanaka A, Oue A, Mori T, Ohtsuki T, Apichartpiyakul C, Uchiumi H, Nojima Y, Hoshino H. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV. AIDS 2009;23:761-769.
47. Stoddart CA,Keir ME,McCuneJM. IFN-alpha-induced upregulation ofCCR5 leads to expanded HIV tropism in vivo. PLoS Pathog 2010;6:e1000766.
48. Sutherland JR, Sales KJ, Jabbour HN, Katz AA. Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo. PLoS One 2012;7:e33848.
49. UNAIDS: Report on Global AIDS epidemic 2008. http://www.unaids.org/en/Dataanalysis/Epidemiology/.
50. Viel T, Schelhaas S,Wagner S,Wachsmuth L, Schwegmann K, Kuhlmann M, Faber C, Kopka K, Schafers M, Jacobs AH. Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging. PLoS One 2013;8:e67911.
51. Wilen CB, Tilton JC,DomsRW. Molecular mechanisms of HIVentry. Adv Exp Med Biol 2012;726:223-242.
52. Wu L, PaxtonWA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-1691.
53. Wu Z, Chen Z, Phillips DM. Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission. J Infect Dis 2003;188:1473-1482.
54. Yeaman GR, Howell AL,Weldon S, Demian DJ, Collins JE, O'Connell DM, Asin SN, Wira CR, Fanger MW. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003; 109:137-146.
55. Yeaman GR, Asin S,Weldon S, Demian DJ, Collins JE, Gonzalez JL, Wira CR, Fanger MW, Howell AL. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology 2004;113:524-533.